Combating Hepatitis C (HCV): A Review of Present & Future Perspectives
Authors
Abstract:
Abstract: Over the past few decades, the race against the treatment strategies of infectious HCV has gained a lot of momentum. These treatments include several therapies like Ribavirin, INF-α, DAA based pro-drugs, vaccines, and even naturally occurring compounds like herbal extracts as well as scorpion venom. All of these drugs have their specialized techniques and methodologies of administration such as combinatorial therapies of several of these drugs combined but still, there is no efficient and ultimate cure. The basic and main reasons include the phenomenon of drug resistance and highly diverse genotypes of HCV. In this review, we have tried to discuss the overall research on these treatment methods and their basic ups and downsides in a nutshell.
similar resources
SARS-CoV-2: A Review Of Present & Future Perspectives
As the dawn of this new decade has begun, we have faced our arch-nemesis right at the start in the form of Coronavirus also known as COVID-19. Since its origin from Wuhan, China, it has been declared a pandemic and has effected several countries worldwide. This review article summarizes all the research, techniques, strategies, and treatment methodologies that are taking place internationally i...
full textExperimental models for hepatitis C virus (HCV): new opportunities for combating hepatitis C.
Infection with hepatitis C virus (HCV) is a global public health issue. More than 200 million people in the world are infected with HCV. Hepatitis C is considered one of the main causes of chronic hepatitis, cirrhosis, hepatocellular carcinoma and liver transplantation. The identification of the viral genome quickly allowed delineation of genomic organization, and the structure and biochemical ...
full textThe present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
The disease burden of hepatitis C virus (HCV) is expected to increase as the infected population ages. A modelling approach was used to estimate the total number of viremic infections, diagnosed, treated and new infections in 2013. In addition, the model was used to estimate the change in the total number of HCV infections, the disease progression and mortality in 2013-2030. Finally, expert pan...
full textEnteric redmouth disease: Past, present and future: A review
Enteric red mouth disease (also known as Yersiniosis) is one of the most significant bacterial infections in coldwater fish farms that cause significant mortalities and economical losses in the salmonids fish farms, especially in rainbow trout (Oncorhynchus mykiss). ERM is caused by the gram negative pathogen bacteria Yersinia ruckeri that has five O-serotypes (O1, O2, O5, O6 and O7), five oute...
full textProphylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives
Studies in patients and chimpanzees that spontaneously clear Hepatitis C Virus (HCV) have demonstrated that natural immunity to the virus is induced during primary infections and that this immunity can be cross protective. These discoveries led to optimism regarding prophylactic HCV vaccines and a number of studies in the chimpanzee model have been performed, all of which resulted in modified i...
full textEnteric redmouth disease: Past, present and future: A review
Enteric red mouth disease (also known as Yersiniosis) is one of the most significant bacterial infections in coldwater fish farms that cause significant mortalities and economical losses in the salmonids fish farms, especially in rainbow trout (Oncorhynchus mykiss). ERM is caused by the gram negative pathogen bacteria Yersinia ruckeri that has five O-serotypes (O1, O2, O5, O6 and O7), five oute...
full textMy Resources
Journal title
volume 14 issue None
pages 0- 0
publication date 2020-06
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023